Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RG7713 (RO 5028442) has been used in trials studying Autistic Disorder.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 121.00 | |
10 mg | In stock | $ 211.00 | |
25 mg | In stock | $ 356.00 | |
50 mg | In stock | $ 533.00 | |
100 mg | In stock | $ 769.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 121.00 |
Description | RG7713 (RO 5028442) has been used in trials studying Autistic Disorder. |
Targets&IC50 | V1a receptor (human):1 nM(Ki), V1a receptor (mouse):39nM(Ki) |
In vitro | RO5028442 (compound 8) has excellent binding in and functional affinity for hV1a, moderate mouse affinity, and excellent selectivity versus human V2 (hV2) and human oxytocin (hOT) receptors. RO5028442 shows high solubility. RO5028442 is found to be highly selective against a panel of 89 targets. Finally, RO5028442 is identified as a suitable compound for clinical studies[1]. |
Synonyms | RO 5028442 |
Molecular Weight | 437.96 |
Formula | C25H28ClN3O2 |
CAS No. | 920022-47-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.38 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RG7713 920022-47-5 GPCR/G Protein Vasopressin Receptor RG-7713 RO 5028442 Inhibitor RG 7713 RO-5028442 RO5028442 inhibit inhibitor